Affordable drug resistance genoty** of HIV-1 reverse transcriptase, protease and integrase genes, for resource limited settings
Background As use of dolutegravir (DTG) becomes more common in resource limited
settings (RLS), the demand for integrase resistance testing is increasing. Affordable …
settings (RLS), the demand for integrase resistance testing is increasing. Affordable …
HIV-1 subtype diversity and factors affecting drug resistance among patients with virologic failure in antiretroviral therapy in Hainan province, China, 2014–2020
YU De E, YJ Xu, LI Mu, Y Yuan, HY Liang… - Biomedical and …, 2023 - Elsevier
Objective This study aimed to determine the HIV-1 subtype distribution and HIV drug
resistance (HIVDR) in patients with ART failure from 2014 to 2020 in Hainan, China …
resistance (HIVDR) in patients with ART failure from 2014 to 2020 in Hainan, China …
Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022
Z Wang, H Jiang, X Pang, J Li, S Liang… - Journal of …, 2024 - academic.oup.com
Objectives To investigate the epidemic patterns of pretreatment drug resistance (PDR) and
acquired drug resistance (ADR) in HIV-1 sequences from China. Methods HIV-1 pol …
acquired drug resistance (ADR) in HIV-1 sequences from China. Methods HIV-1 pol …
[HTML][HTML] Patterns of HIV-1 Drug Resistance Observed Through Geospatial Analysis of Routine Diagnostic Testing in KwaZulu-Natal, South Africa
HIV-1 drug resistance (HIVDR) impedes treatment and control of HIV-1, especially in high-
prevalence settings such as KwaZulu-Natal (KZN) province, South Africa. This study merged …
prevalence settings such as KwaZulu-Natal (KZN) province, South Africa. This study merged …
Geospatial and temporal map** of detectable HIV-1 viral loads amid dolutegravir rollout in KwaZulu-Natal, South Africa
L Gounder, A Tomita, R Lessells… - PLOS Global Public …, 2024 - journals.plos.org
South Africa rolled out dolutegravir (DTG) as first-line antiretroviral therapy (ART) in
December 2019 to overcome high rates of pretreatment non-nucleoside reverse …
December 2019 to overcome high rates of pretreatment non-nucleoside reverse …
Brief communication: The rate of switching from first-line to second-line antiretroviral therapy among people living with HIV in Aden City, Yemen
NM Al-Haidary, EA Radman - AIDS Research and Therapy, 2024 - Springer
Background Effective management of antiretroviral therapy (ART) is crucial in combating the
global HIV pandemic. This study, the first of its kind in Yemen, investigates the rate and …
global HIV pandemic. This study, the first of its kind in Yemen, investigates the rate and …
Virological, weight, and drug resistance outcomes among patients initiating a dolutegravir-based first line ART regimen in Zimbabwe
V Kouamou, T Washaya, T Mapangisana, CE Ndhlovu… - AIDS, 2022 - journals.lww.com
Objective: Dolutegravir (DTG)-based ART is being scaled up in Africa. However, clinical
experience with DTG and patterns of HIV drug resistance (HIVDR) are sparse in Zimbabwe …
experience with DTG and patterns of HIV drug resistance (HIVDR) are sparse in Zimbabwe …
Prevalence, predictors and geospatial patterns of HIV drug resistance in South Africa: Insights from the 2017 national HIV household survey
Background South Africa bears the highest HIV burden globally, marked by a substantial
expansion of antiretroviral therapy (ART) that curbs HIV and AIDS cases, morbidity, and …
expansion of antiretroviral therapy (ART) that curbs HIV and AIDS cases, morbidity, and …
Validation of a Low-cost in-house Hiv Integrase Inhibitor Drug-resistance Assay and Characterization of the Pol-Integrase Region From Patients Failing Treatment at …
VM Onwonga - 2022 - erepository.uonbi.ac.ke
Background: HIV drug resistance testing (DRT) plays an essential role in the surveillance of
HIV drug resistance (HIVDR) and informs on the effectiveness of treatment regimens for …
HIV drug resistance (HIVDR) and informs on the effectiveness of treatment regimens for …